Kalbe Farma Logo
ID1000125107
A1J5U9
KLBF.JK

Kalbe Farma

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2026, Kalbe Farma has already paid €0.000979 in dividends. The last payout was in June.

Financials

In the last quarter, Kalbe Farma had revenue of €468.04m and net profit of €40.29m
(EUR) September 2026
YoY
Revenue 468.04m 2.90%
Gross profit 171.75m 0.88%
Net profit 40.29m 20.23%
EBITDA 57.18m 3.24%

Fundamentals

Metric Value
Market capitalization
€1.78bn
Number of shares
45.19bn
52-week high/low
€0.0637 - €0.0314
Dividend yield
3.26%
Dividends TTM
€0.000979
Beta
0.52
P/E ratio
9.49
PEG ratio
1.11
P/B ratio
1.42
P/S ratio
0.93

Company profile

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Name
Kalbe Farma
CEO
Bernadette Ruth Irawati Setiady
Headquarters Jakarta, jk
Indonesia
Website
IPO
15/12/2003
Employees 12,806

Ticker symbols

Exchange Symbol
Jkt
KLBF.JK
Pnk
PTKFF
Frankfurt
LCLA.F
München
LCLA.MU
🍪

Parqet  uses cookies. Learn more